Cargando…

Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review

The COVID-19 pandemic has spurred a hasty transition to virtual care but also an abundance of new literature highlighting telehealth’s capabilities and limitations for various healthcare applications. In this review, we aim to narrate the current state of the literature on telehealth applied to migr...

Descripción completa

Detalles Bibliográficos
Autores principales: Noutsios, Constantinos Dean, Boisvert-Plante, Virginie, Perez, Jordi, Hudon, Jonathan, Ingelmo, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179807/
https://www.ncbi.nlm.nih.gov/pubmed/34103978
http://dx.doi.org/10.2147/JPR.S309542
_version_ 1783703866844381184
author Noutsios, Constantinos Dean
Boisvert-Plante, Virginie
Perez, Jordi
Hudon, Jonathan
Ingelmo, Pablo
author_facet Noutsios, Constantinos Dean
Boisvert-Plante, Virginie
Perez, Jordi
Hudon, Jonathan
Ingelmo, Pablo
author_sort Noutsios, Constantinos Dean
collection PubMed
description The COVID-19 pandemic has spurred a hasty transition to virtual care but also an abundance of new literature highlighting telehealth’s capabilities and limitations for various healthcare applications. In this review, we aim to narrate the current state of the literature on telehealth applied to migraine care. First, telemedicine in the context of non-acute headache management has been shown to produce non-inferior patient outcomes when compared to traditional face-to-face appointments. The assignment of patients to telehealth appointments should be made after referring more urgent cases to dedicated in-person clinics. During the virtual appointment, physicians can ask their patients about the “3 F’s” in order to perform a thorough assessment of their headaches: frequency of headache days, frequency of acute medication usage and functional impairment. Clinical assessment scores that have been studied and deemed feasible for telemedicine, safe and efficient include the HIT-6, VAS and MIDAS scores. Although MIDAS was found to be redundant and inadequate to use on a daily basis, we suggest that it can be useful in periodic remote follow-up appointments. Additionally, several mobile health apps have been studied including Migraine Buddy, Migraine Coach and Migraine Monitor. All of these are appropriate for use in telemedicine when combined with an adequate trial period with Migraine Buddy being rated the highest, as it captures the most detailed clinical picture. High satisfaction rates have been reported for virtual headache management which were shown to be equal to in-person consults. These are based on patients’ perceived increase in convenience due to avoided travel time, less disruption of their daily routine and feeling more comfortable in the environment of their choice. Despite this, limitations such as technological knowledge, access to videoconferencing modalities and having a more impersonal consultation with the physician may hinder some patients from adopting this service.
format Online
Article
Text
id pubmed-8179807
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81798072021-06-07 Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review Noutsios, Constantinos Dean Boisvert-Plante, Virginie Perez, Jordi Hudon, Jonathan Ingelmo, Pablo J Pain Res Review The COVID-19 pandemic has spurred a hasty transition to virtual care but also an abundance of new literature highlighting telehealth’s capabilities and limitations for various healthcare applications. In this review, we aim to narrate the current state of the literature on telehealth applied to migraine care. First, telemedicine in the context of non-acute headache management has been shown to produce non-inferior patient outcomes when compared to traditional face-to-face appointments. The assignment of patients to telehealth appointments should be made after referring more urgent cases to dedicated in-person clinics. During the virtual appointment, physicians can ask their patients about the “3 F’s” in order to perform a thorough assessment of their headaches: frequency of headache days, frequency of acute medication usage and functional impairment. Clinical assessment scores that have been studied and deemed feasible for telemedicine, safe and efficient include the HIT-6, VAS and MIDAS scores. Although MIDAS was found to be redundant and inadequate to use on a daily basis, we suggest that it can be useful in periodic remote follow-up appointments. Additionally, several mobile health apps have been studied including Migraine Buddy, Migraine Coach and Migraine Monitor. All of these are appropriate for use in telemedicine when combined with an adequate trial period with Migraine Buddy being rated the highest, as it captures the most detailed clinical picture. High satisfaction rates have been reported for virtual headache management which were shown to be equal to in-person consults. These are based on patients’ perceived increase in convenience due to avoided travel time, less disruption of their daily routine and feeling more comfortable in the environment of their choice. Despite this, limitations such as technological knowledge, access to videoconferencing modalities and having a more impersonal consultation with the physician may hinder some patients from adopting this service. Dove 2021-06-01 /pmc/articles/PMC8179807/ /pubmed/34103978 http://dx.doi.org/10.2147/JPR.S309542 Text en © 2021 Noutsios et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Noutsios, Constantinos Dean
Boisvert-Plante, Virginie
Perez, Jordi
Hudon, Jonathan
Ingelmo, Pablo
Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title_full Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title_fullStr Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title_full_unstemmed Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title_short Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review
title_sort telemedicine applications for the evaluation of patients with non-acute headache: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179807/
https://www.ncbi.nlm.nih.gov/pubmed/34103978
http://dx.doi.org/10.2147/JPR.S309542
work_keys_str_mv AT noutsiosconstantinosdean telemedicineapplicationsfortheevaluationofpatientswithnonacuteheadacheanarrativereview
AT boisvertplantevirginie telemedicineapplicationsfortheevaluationofpatientswithnonacuteheadacheanarrativereview
AT perezjordi telemedicineapplicationsfortheevaluationofpatientswithnonacuteheadacheanarrativereview
AT hudonjonathan telemedicineapplicationsfortheevaluationofpatientswithnonacuteheadacheanarrativereview
AT ingelmopablo telemedicineapplicationsfortheevaluationofpatientswithnonacuteheadacheanarrativereview